Comparison of primary tumour volumes delineated on four-dimensional computed tomography maximum intensity projection and (18) F-fluorodeoxyglucose positron emission tomography computed tomography images of non-small cell lung cancer

Journal of Medical Imaging and Radiation Oncology
Yili DuanDongping Shang

Abstract

The study aims to compare the positional and volumetric differences of tumour volumes based on the maximum intensity projection (MIP) of four-dimensional CT (4DCT) and (18) F-fluorodexyglucose ((18) F-FDG) positron emission tomography CT (PET/CT) images for the primary tumour of non-small cell lung cancer (NSCLC). Ten patients with NSCLC underwent 4DCT and (18) F-FDG PET/CT scans of the thorax on the same day. Internal gross target volumes (IGTVs) of the primary tumours were contoured on the MIP images of 4DCT to generate IGTVMIP . Gross target volumes (GTVs) based on PET (GTVPET ) were determined with nine different threshold methods using the auto-contouring function. The differences in the volume, position, matching index (MI) and degree of inclusion (DI) of the GTVPET and IGTVMIP were investigated. In volume terms, GTVPET 2.0 and GTVPET 20% approximated closely to IGTVMIP with mean volume ratio of 0.93 ± 0.45 and 1.06 ± 0.43, respectively. The best MI was between IGTVMIP and GTVPET 20% (0.45 ± 0.23). The best DI of IGTVMIP in GTVPET was IGTVMIP in GTVPET 20% (0.61 ± 0.26). In 3D PET images, the GTVPET contoured by standardised uptake value (SUV) 2.0 or 20% of maximal SUV (SUVmax ) approximate closely to the IGTVMIP in targe...Continue Reading

References

Mar 26, 2003·International Journal of Radiation Oncology, Biology, Physics·Curtis B CaldwellCyril E Danjoux
Jul 21, 2004·Medical Physics·S A NehmehJ L Humm
Aug 23, 2005·International Journal of Radiation Oncology, Biology, Physics·René W M UnderbergSuresh Senan
Nov 23, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jeffrey D BradleyDivya Khullar
Feb 28, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Joe Y ChangRitsuko Komaki
Apr 15, 2008·International Journal of Radiation Oncology, Biology, Physics·Michael P Macmanus, Rodney J Hicks
May 26, 2009·International Journal of Radiation Oncology, Biology, Physics·Jinming YuC Clifton Ling
Aug 12, 2009·International Journal of Radiation Oncology, Biology, Physics·Gerard G HannaAlan R Hounsell
Sep 29, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Holger HofKlaus Herfarth
Jun 24, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Gitte Fredberg PerssonStine Sofia Korreman
Jul 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Michael BayneMichael MacManus
Aug 17, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Valentino BettinardiCristina Messa
Apr 5, 2011·European Journal of Radiology·Valentina AmbrosiniStefano Fanti
May 10, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Feng Xiang LiChang Sheng Ma
Nov 15, 2011·Australasian Physical & Engineering Sciences in Medicine·J CallahanT Kron
Dec 27, 2011·International Journal of Radiation Oncology, Biology, Physics·Guoping ChangOsama R Mawlawi
Jun 13, 2012·International Journal of Radiation Oncology, Biology, Physics·Hong GeFang-Fang Yin
Apr 23, 2013·International Journal of Radiation Oncology, Biology, Physics·Jason CallahanRodney J Hicks

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.